Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells

Journal of the National Cancer Institute

Volumn 93, Issue 19, 2001, Pages 1465-1472

  Nguyen, Carvell ^a   Liang, Gangning ^a   Nguyen, TuDung T ^a   Tsao Wei, Denice ^a   Groshen, Susan ^a   Lübbert, Michael ^b   Zhou, Jain Hua ^c   Benedict, William F ^c   Jones, Peter A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; PROTEIN P15; PROTEIN P16; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX 6; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL SELECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA DETERMINATION; DNA METHYLATION; EXON; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; MYELODYSPLASTIC SYNDROME; NERVE CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; SOLID TUMOR; TRANSCRIPTION INITIATION;

EID: 0035802289     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.19.1465     Document Type: Article

References (29)

1. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies
2. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
3. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
4. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
5. CpG islands as gene markers in the human genome
6. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines
7. PAX6 methylation and ectopic expression in human tumor cells
8. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene
9. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)
10. Statistical methods
11. Tables for normal tolerance limits, sampling plans, and screening
12. Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure
13. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs
14. Repression of genes by DNA methylation depends on CpG density and promoter strength: Evidence for involvement of a methyl-CpG binding protein
15. The unmethylated state of CpG islands in mouse fibroblasts depends on the poly(ADP-ribosyl)ation process
16. Reduced levels of poly(ADP-ribosyl)ation result in chromatin compaction and hypermethylation as shown by cell-by-cell computer-assisted quantitative analysis
17. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia
18. Aberrant promoter methylation of multiple genes in non-small cell lung cancers
19. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype
20. CpG island methylator phenotype in colorectal cancer
21. Hyper-methylation of multiple genes in pancreatic adenocarcinoma
22. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
23. CpG-island methylation in aging and cancer
24. Analysis of cyclin-dependent kinase inhibitor expression and methylation patterns in human prostate cancers
25. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia
26. The DNA methylation paradox
27. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes
28. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression
29. Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: Biological implications